Jason Pickney, FNP-C | |
2895 Lewis Ln, Paris, TX 75460-9331 | |
(972) 203-3600 | |
Not Available |
Full Name | Jason Pickney |
---|---|
Gender | Male |
Speciality | Nurse Practitioner |
Experience | 8 Years |
Location | 2895 Lewis Ln, Paris, Texas |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1942748678 | NPI | - | NPPES |
Facility Name | Location | Facility Type |
---|---|---|
Dallas Regional Medical Center | Mesquite, TX | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Star Md Pllc | 2860773389 | 14 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.
Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.
The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.
Kaiser Health News staff writer Julie Appleby explores the following concept advanced in current health overhaul plans. "Both the House measure and the newly recast Senate bill would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.
› Verified 8 days ago
Entity Name | Frederic J Simmons |
---|---|
Entity Type | Practitioner - General Practice |
Entity Identifiers | NPI Number: 1952318750 PECOS PAC ID: 8921139494 Enrollment ID: I20100628000143 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.
Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.
The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.
Kaiser Health News staff writer Julie Appleby explores the following concept advanced in current health overhaul plans. "Both the House measure and the newly recast Senate bill would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.
› Verified 8 days ago
Entity Name | Questcare Hospitalists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1265441620 PECOS PAC ID: 5799785119 Enrollment ID: O20070109000581 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.
Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.
The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.
Kaiser Health News staff writer Julie Appleby explores the following concept advanced in current health overhaul plans. "Both the House measure and the newly recast Senate bill would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.
› Verified 8 days ago
Entity Name | Star Md Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1972059392 PECOS PAC ID: 2860773389 Enrollment ID: O20161221001053 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.
Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.
The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.
Kaiser Health News staff writer Julie Appleby explores the following concept advanced in current health overhaul plans. "Both the House measure and the newly recast Senate bill would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.
› Verified 8 days ago
Entity Name | Integrity Md Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1912775834 PECOS PAC ID: 9436500048 Enrollment ID: O20240109000134 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.
Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.
The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.
Kaiser Health News staff writer Julie Appleby explores the following concept advanced in current health overhaul plans. "Both the House measure and the newly recast Senate bill would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.
› Verified 8 days ago
Mailing Address | Practice Location Address |
---|---|
Jason Pickney, FNP-C Po Box 1200, Colleyville, TX 76034-1200 Ph: (972) 203-3600 | Jason Pickney, FNP-C 2895 Lewis Ln, Paris, TX 75460-9331 Ph: (972) 203-3600 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC - James) suggests that an unusual experimental drug can reduce breast-cancer aggressiveness, reverse resistance to the drug fulvestrant and perhaps improve the effectiveness of other breast-cancer drugs.
Today, the Jayne Koskinas Ted Giovanis Foundation announced over $160K in awards to support the next generation of health policy research and promote better healthcare for patients. Four graduate researchers in the field of health policy and administration at Brown University, Georgetown University, Harvard University and The Johns Hopkins University received Dissertation Support Grants (DSGs) to aid their research.
The U.S. Food and Drug Administration is taking immediate steps to help reduce the risk of spreading unsuspected cancer in women being treated for uterine fibroids, which is in keeping with Kalorama Information's view that in the female health market there is much room for improvement both in the development of products and the treatment of diseases.
Kaiser Health News staff writer Julie Appleby explores the following concept advanced in current health overhaul plans. "Both the House measure and the newly recast Senate bill would force insurers to spend the vast majority of premium revenue on medical care for their customers, reducing the amount available for profits, executive salaries, sales and administration.
› Verified 8 days ago
Kimberly Smith, MSN, APRN, FNP-BC Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2895 Lewis Ln, Paris, TX 75460 Phone: 972-203-3600 |